Connectivity and Digital Health in Medical Technology

The latest technologies in connected medical devices, digital health and mobile apps for the pharmaceutical and medical device industries

Conference overview

Our media partner

We are in the midst of an innovative period in medical technology and digital health and this brings huge opportunities for the pharmaceutical and medical device industries to revolutionise drug delivery. The market size in this area is expected to grow rapidly and a key goal for major players is to harness these technological advances to improve patient safety, experience, convenience and compliance, whilst meeting the regulatory requirements and complying with the legal demands surrounding data security.
Key experts from a variety of disciplines in the areas of connected drug delivery and digital health will explore ways to exploit the technology available to enhance drug delivery and will discuss the challenges, opportunities and how to:

  • Monetise the benefits associated with a connected medical device
  • Securely handle the data which a connected medical device will generate
  • Help the healthcare professional maximise the use of connected medical technology

This programme will provide valuable insights into the use of connected devices for drug delivery and will enable you to:

  • Understand the benefits connectivity in medical technology brings to various stakeholders
  • Hear how leading pharmaceutical and medical device companies are improving design features to enhance patient usability and compliance
  • Plan your strategy for digital health solutions and understand the legal requirements
  • Comply with the regulatory requirements surrounding software and medical apps
  • Discuss with industry leaders the opportunities connectivity in healthcare can offer

Exhibitor

Benefits of attending

  • Explore the need for connectivity in the future of healthcare
  • Understand how strong security and looking after personal data should enable better healthcare
  • Be aware of the legal issues around cybersecurity and how to deal with data breaches
  • Learn about successful multi-sensor remote data collection
  • Discuss the opportunities for connectivity in drug delivery
  • Gain insight into the latest technologies including smart inhalers, injectables, wearables and eye tracking
  • Clarify the MDR and FDA requirements for medical device software
  • Hear about developing digital health systems using connectivity
  • Consider the use of smart packaging to improve patient outcomes through targeted application of smart technologies

Who should attend

  • Technical, marketing and commercial seniors
  • Global medical device development managers
  • Business development managers
  • Digital health professionals
  • Senior connectivity engineers
  • Developers of connected medical devices
  • Smart technology developers
  • Pharmaceutical professionals
  • Regulatory managers and government associates
  • Leaders in device data generation
  • Digital health managers
  • Device data managers
  • Novel product developers
  • Packaging professionals
  • Human factor directors
  • Connectivity scientists
  • Marketing professionals promoting connected medical devices
  • Those with conventional medical devices who wish to introduce connectivity

Programme - Day one

Chair’s welcome and introduction

Dr Gregory Berman

Opening address: How pharmaceutical companies and drug delivery device developers integrate connectivity into innovative health solutions

  • The need for connectivity in the future of healthcare
  • The opportunities for improved patient experience
  • Tackling the medical adherence challenge
  • How to build connected healthcare solutions via connected devices, digital interface and the cloud platform
  • The multi benefits for secure connected health platforms

Neil Williams

Key aspects of how better security and good governance over personal data will enable better global healthcare

  • How strong security and looking after personal data should enable better healthcare
  • Malware, the security of medical devices in the internet of things
  • The impact of privacy on digital health

Caroline Rivett

Understanding legal risk from data breaches in the digital health ecosyste

  • Preparation is the best response
  • Effective breach response management – dos and don’ts
  • Data litigation after a breach – where are we now, and what to expect in future

Paul Glass

Panel discussion: Is our health data safe?

  • How to keep digital data secure
  • Cybersecurity and malware
  • Importance of privacy on digital health

Led by Dr Gregory Berman with Neil Williams, Caroline Rivett and Paul Glass

Multi-sensor remote data collection – critical success factors

  • Device selection
  • Data aggregation
  • The importance of patient engagement
  • Data analyses
  • How to achieve a successful outcome

Marie McCarthy (tbc)

Next generation drug delivery: needle-free and connectivity

  • Adherence to treatment in injectable therapies for chronic disease is very low (40% – 60%)
  • There is an opportunity for a new form of drug delivery to change this paradigm and transform the perception and approachability of such therapies
  • Connectivity in drug delivery enables the provider to be closer to their patients, know how their patients use their medicines and embed positive feedback loops to improve outcomes
  • Case study: A needle-free drug delivery device such as the one developed by Portal can help solve the needle anxiety problem plaguing the access to biological therapies

Patrick Anquetil

Digital education in endoscopy

  • Supporting the aims of the NHS Long Term Plan through the application of a digital education pathway
    - Earlier cancer diagnosis
    - Digitalisation of the NHS
    - Workforce support
  • Improving the efficiency and capacity of UK endoscopy services
    - Reducing DNA (Did Not Attend) through enhanced education and support
    - Improve bowel prep and reduce unnecessary repeat procedures
    - Unburden admin team to focus on patient needs

Francis White

Smart packaging – improving patient outcomes through targeted application of smart technologies

  • Smart packaging – what is it and some examples
  • Why are patient outcomes sub-optimal?
  • How to improve these outcomes using smart packaging
  • The opportunities smart packing can bring to the patient experience
  • Case study

Chris Waterhouse

Programme - Day two

Review of day one

Dr Gregory Berman

Why medical technology needs to get serious about investing in digital health

  • The growing importance of digital products and services
  • Are they a potential threat to the traditional business models or a huge opportunity for partnerships and expansion into new markets?

John Jeans

Regulatory requirements for connected medical devices

  • Understanding the regulatory framework of EU MDR and FDA
  • Cybersecurity, data privacy and risk identification
  • Implications for product development and maintenance
  • Future perspectives of IoT-enabled devices

Mette Luxhøj

Digital health partnering agreements

  • Considering key IP and commercial provisions and pitfalls to avoid in partnering agreements
  • Considering the restrictions and practical aspects for licensing public health datasets in different jurisdictions
  • Balancing IP rights and maintaining the confidentiality of data with third-party rights and interests

Colin McCall and Jo Joyce

Innovative technology approach in wearable health – example of a successful cooperation between research institutes and industrial players

  • Datwyler Inc and IMEC – brief introduction
  • Innovative technology approach in detection of vital signs, i.e. ExG
  • Industrialisation and market introduction

Thilo Schmierer

Connecting the dots between patients and medical devices

  • Connected drug delivery devices are here now and will be a part of the future
  • Which disease indications, patient groups and devices are they appropriate for?
  • How does connectivity affect device development?
  • How can you ensure success over the lifetime of a device?
  • Adherence and usability in a connected world

Rob Udale

Successful implementation of connected drug delivery devices: lessons from diabetes

  • Obvious needs for connectivity: complex treatment management, many factors involved, a number of parameters to follow and lots of tools to master
  • Glucose monitoring and diabetes management players already offer successful connected tools and software solutions
  • There is a strong requirement to ‘close the loop’ by tracking insulin delivery information
  • Beyond diabetes: discussion of other areas that present similar characteristics such as respiratory and CVC

Arnaud Guillet

Eye tracking evolution in medical device development

  • What is eye tracking?
  • Recent growth of eye tracking
  • Future developments of eye tracking
  • The use of eye tracking in usability studies
  • The application of scan paths and heat map technology to identify similarities in participants’ responses

Phil Seeney

Chair’s concluding remarks

Book now

We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.

You may also be interested in

Previous customers include...

  • Advanex Europe Ltd
  • Aptar France SAS
  • APTAR FRANCE SAS (VALOIS SAS)
  • Becton Dickinson
  • Biocorp
  • Biogen
  • Cantab Innovations
  • Chiesi Farmaceutici S.p.a.
  • Debiopharm International SA
  • Ferring Pharmaceuticals
  • Haselmeier AG
  • Lastow Consulting
  • Medela AG
  • Noble International
  • Nokia
  • Nordic Semiconductor
  • Novo Nordisk A/S
  • OnDrugDelivery Ltd
  • Owen Mumford Ltd
  • PA Consulting
  • PDD Group Ltd
  • Presspart Manufacturing Ltd
  • Quanta Dialysis Technologies Ltd
  • Sagentia Limited
  • Semigator GmbH
  • SHL Group
  • Smith & Nephew
  • SPD Development Company Ltd
  • Springboard
  • Ypsomed AG

I feel the course was very useful and provided an good understanding of connectivity in medical technology and has opened my mind to the many challenges but benefit of connectivity in medical technology.

Paul Fitton, Regulatory Affairs Specialist, Presspart

Good overall overview

Frederic Bustos, Quality and Regulatory Affairs Manager, Cochlear Ltd

Quality of speakers and ability to present very good.

Stefan Gaul, Head of Strategic Product Management, Haselmeier AG

A lot of focus on describing status of industry and issues but little insight into innovations and technical solutions. Some talks lacked technical depth with was disappointing.

James Gani, Design Team Leader, SPD Development Company Ltd

Very well organised and a nice broad range of topics. Some very good speakers and interesting talks.

David Harris, Scientist and Inventor, PA Consulting

Very good

Arun Sarda, Global Director, QA & Regulatory Affairs, Presspart Manufacturing Ltd

Good

Arnaud Guillet, Business Development Director , Biocorp

Provides wide overview, interesting presentations, well prepared speakers

Stefan Gaul, Head of Strategic Product Management, Haselmeier AG